advertisement
Editors Selection IGR 13-4
List of Editor's Selection comments by
Makoto Araie
Director, Sekikawa Hospital, Tokyo, Japan
Medical Treatment: ROCK Inhibitor Mechanism of Action (22-2, December 2021) on:
94676 Netarsudil Improves Trabecular Outflow Facility in Patients with Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 2 Study
Sit AJ; Gupta D; Kazemi A et al.
American Journal of Ophthalmology 2021; 226: 262-269
Clinical Examination Methods: Ocular Hemodynamics (20-2, November 2019) on:
80085 Ocular Hemodynamics in Acute Nonarteritic Anterior Ischemic Optic Neuropathy Compared With Normal Tension Glaucoma
Kuerten D; Fuest M; Bienert M et al.
Journal of Glaucoma 2019; 28: 334-340
Blood Flow: Oxygen saturation and VF damage (13-4, April 2012) on:
47975 Retinal oximetry in primary open-angle glaucoma
Olafsdottir OB; Hardarson SH; Gottfredsdottir MS et al.
Investigative ophthalmology & visual science 2011; 52: 6409-6413
Basic Research: RGC death and lomerizine (11-4, March 2010) on:
24832 Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine
Fitzgerald M; Payne SC; Bartlett CA et al.
Investigative Ophthalmology and Visual Science 2009; 50: 5456-5462
Comments (9-4, March 2008) on:
20036 Predictors of long-term progression in the Early Manifest Glaucoma Trial
Leske MC; Heijl A; Hyman L et al.
Ophthalmology 2007; 114: 1965-1972
Medical Therapy: Preservatives in eye drops (9-3, December 2007) on:
19601 In Vitro Studies of Antiglaucomatous Prostaglandin Analogues: Travoprost with and without Benzalkonium Chloride and Preserved Latanoprost
Baudouin C; Riancho L; Warnet JM et al.
Investigative Ophthalmology and Visual Science 2007; 48: 4123-4128
Neuroprotection: MK801 (8-1, June 2006) on:
13521 Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo
Guo L; Salt TE; Maass A et al.
Investigative Ophthalmology and Visual Science 2006; 47: 626-633
